Latest news
Loading news…
Pulmatrix develops inhaled therapies for the treatment, prevention and transmission of infectious and progressive respiratory diseases.
Pulmatrix was acquired by Eos SENOLYTIX in 2026.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
28
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Framingham, Massachusetts, United States
Acquisitions by Pulmatrix
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Pulmatrix
Co-Founder
Vice President of Pharmaceutical Development
28
professional contacts at Pulmatrix
Contact execs at Pulmatrix →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Pulmatrix
Loading news…
FAQs about Pulmatrix
People who checked this page also checked these
Sectors Pulmatrix invests & acquires in
Browse the full Acquirezy directory.